Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
about
Correlating corneal arcus with atherosclerosis in familial hypercholesterolemiaThe effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stressArsenic exposure accelerates atherogenesis in apolipoprotein E-/-miceCharacterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoproteinRegulation of macrophage foam cell formation by alphaVbeta3 integrin: potential role in human atherosclerosisMacrophage colony-stimulating factor gene expression in vascular cells and in experimental and human atherosclerosisVitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidantOxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidationIdentification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptorHuman macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesionsOxidants, antioxidants, and the degenerative diseases of agingImmunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patientsDisruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient miceSpecific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenaseAutoxidation of lipids and antioxidation by alpha-tocopherol and ubiquinol in homogeneous solution and in aqueous dispersions of lipids: unrecognized consequences of lipid particle size as exemplified by oxidation of human low density lipoproteinUbiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherolVitamins C and E: beneficial effects from a mechanistic perspectiveCocoa, chocolate, and cardiovascular diseaseFlavonoids and heart diseaseCoexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesionsAntioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavengingThe relationship between dose of vitamin E and suppression of oxidative stress in humansCD36 mRNA and Protein Expression Levels Are Significantly Increased in the Heart and Testis of apoE Deficient Mice in Comparison to Wild Type (C57BL/6).A simple method to assess the oxidative susceptibility of low density lipoproteinsPotential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal womenThe association of the PON1 Q192R polymorphism with coronary heart disease: findings from the British Women's Heart and Health cohort study and a meta-analysisDiabetes DyslipidemiaMonocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and TherapyAlbumin-based drug delivery: harnessing nature to cure diseaseRoles of antibody against oxygenized low density lipoprotein in atherosclerosis: recent advancesLDL electronegativity index: a potential novel index for predicting cardiovascular diseaseClinical Relevance of Biomarkers of Oxidative StressLipoprotein-associated oxidative stress: a new twist to the postprandial hypothesisOxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitusImplications of autophagy for vascular smooth muscle cell function and plasticityPharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.Lipid peroxidation and its toxicological implicationsPostprandial lipemic and inflammatory responses to high-fat meals: a review of the roles of acute and chronic exerciseRedox Roles of Reactive Oxygen Species in Cardiovascular DiseasesThe HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences
P2860
Q21093276-4F868B06-EDB9-42E7-A2F5-D7BC91A6EE60Q21093277-313FD9A6-DA33-40D5-8B1D-0B995CB3DEE9Q23919503-0786C309-04D1-4D20-998E-FDE932E495EFQ24294419-8330BE46-FCDB-428C-9510-549111F6C84DQ24297558-D7662CA7-C147-4625-9DF4-4AE7232AEE1DQ24301047-31999C00-1EDD-4184-86E9-8EBA9066C15DQ24527411-95D8B91B-EE40-4F07-AE1F-DB85AA8AC334Q24528264-767C6028-A66D-4A1C-A9B9-C7FE007413C9Q24531178-051B0B1D-D89D-43F5-8C53-B0E5F84B4C61Q24556582-221DF667-DDEA-46E9-9651-939569013937Q24561734-6724C85C-7ED8-4131-B26D-E5C64B81C1B8Q24561776-156DD462-1467-4A91-8AA7-177AC34DABA1Q24563208-650543DF-FFF2-4BFD-8880-729439BCBC2AQ24563459-E0FBD4E0-F641-43A2-B1D4-12748CE3D4F2Q24563896-A2CD6CC1-48FF-42DC-9BE5-F1C1ECDCB290Q24564131-EFDAD3A4-703F-4381-A657-B64B5B0B525EQ24617202-67086031-78CF-4ECB-8F5E-A84A9428AA89Q24654705-A912060E-FE5B-466A-8A8B-C6AB47184432Q24655689-1503D65C-32E6-48BA-B5C9-6B52839B34A5Q24676740-1A70D776-0034-426E-8027-9DD4E1B4A7DFQ24676858-8DF39EEA-E2CA-4917-A5B1-1D8252078605Q24680423-F19E37EC-A117-421B-A5DE-37F02115F499Q24791158-4023ED83-2217-4FFC-80D3-E175C1985203Q24800361-040BB4A3-299D-4D6D-AEA6-279202208E4CQ24800416-B127F371-2DD7-4B54-8CFB-9300E56D5C91Q24801635-814A8F42-2D80-43F5-8A22-A243AFA95081Q26750905-6E88FA4D-2B77-44AA-9E26-D97ECB5234ACQ26765189-08215340-BDAB-47DA-93EE-85859810B551Q26765789-78EE4E6F-2A77-491F-86B8-0731F008DB80Q26778507-B245BF6A-386E-4CBA-A621-4C3684D82571Q26781851-77FE5D1D-42FE-4647-B0B0-D21E14B56D15Q26785512-4865AE29-D57F-4E16-A5A1-D0D650CBB12CQ26828643-3CEEA266-9675-4B10-B1E5-40BF7836E892Q26829529-B692856A-0914-40C4-90CA-4B673DA9DEE0Q26863422-5525955D-E38D-4146-B09F-CC306E6B734DQ27332892-3A98EDF9-8650-4039-B28A-0283914E23AEQ27691302-16911E7C-552D-462F-9170-75C59480165AQ28075762-18DDA9AB-9A03-4E0B-A397-7CBFFD55DCD8Q28082072-45069D2D-27DF-4047-9735-96EB9E5E7092Q28188518-1BEA0593-EB38-4652-AF68-4BAA4DD723B3
P2860
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Beyond cholesterol. Modificati ...... at increase its atherogenicity
@ast
Beyond cholesterol. Modificati ...... at increase its atherogenicity
@en
type
label
Beyond cholesterol. Modificati ...... at increase its atherogenicity
@ast
Beyond cholesterol. Modificati ...... at increase its atherogenicity
@en
prefLabel
Beyond cholesterol. Modificati ...... at increase its atherogenicity
@ast
Beyond cholesterol. Modificati ...... at increase its atherogenicity
@en
P2093
P3181
P1476
Beyond cholesterol. Modificati ...... at increase its atherogenicity
@en
P2093
Parthasarathy S
Steinberg D
Witztum JL
P304
P3181
P356
10.1056/NEJM198901053200122
10.1056/NEJM198904063201407
P407
P577
1989-04-06T00:00:00Z